Neurofibromatosis Type 2 - 25 Studies Found
Completed |
: Analysis of NF2 Mutations in Radiation-Related Neural Tumors : Neural Tumors : 2006-06-19 |
Recruiting |
: Vismodegib and FAK Inhibitor GSK2256098 in Treating Patients With Progressive Meningiomas :
|
Recruiting |
: Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 Mutations :
: 2015-01-28 : Drug: Everolimus Other Names:
|
Completed |
: Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity : Malignant Pleural Mesothelioma : 2009-12-02 : Drug: everolimus Everolimus will be administered at a dose of 10mg orally once daily continuously. Dose |
Recruiting |
: Exploring the Activity of RAD001 in Vestibular Schwannomas and Meningiomas :
: Drug: RAD001 Other Name: Everolimus |